3.76
price up icon5.32%   0.19
after-market Handel nachbörslich: 3.60 -0.16 -4.26%
loading

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
0.03%
3.676
3.677 3.272 2.543 3.618
Operating Income/Loss
1.83%
-5.741
-5.848 -5.157 -4.741 -5.521
Income/Loss From Continuing Operations Before Tax
0.10%
-5.144
-5.139 -4.464 -4.47 -5.265
Income Tax Expense/Benefit
68.18%
0.007
0.022 0.007 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Net Income/Loss
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,991%
37.96
1.8154 37.95 27.31 26.45
Basic Earnings Per Share
0.00%
-0.14
-0.14 -0.12 -0.16 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):